05.09.18
Alastin Skincare has announced the appointment of James P. Hartman to the position of Chief Commercial Officer effective May 14, 2018.
Alastin Skincare is a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products. The products are made with the brand's proprietary TriHex Technology, which it says will enhance, protect, and maintain healthy skin for a lifetime.
Hartman holds a proven track record of successful business leadership and development of leading brands in the medical aesthetics arena. He most recently served as vice president & general manager at Solta Medical, a division of Valeant Pharmaceuticals.
Diane S. Goostree, president/CEO, Alastin Skincare says, "Jim's extensive operating background in the medical aesthetics space, including experience with energy-based rejuvenating devices, is a natural fit for us as we develop and launch new products and expand our sales force."
Hartman adds, "Minimally invasive rejuvenating procedures are a fast-growing segment of the aesthetics industry, and differentiated, efficacious products such as Alastin's Procedure Enhancement line provide optimal outcomes and reduced downtime for patients while building physicians' practices and the aesthetic market overall."
